Fortis Malar Hospitals Limited

BSE: FORTISMLR523696ISIN INE842B01015

Healthcare
Hospital

BSE listing

Share price

₹41.95+0.64 (+1.55%)

as of 18 Sep 2026

52W high: ₹76.00
52W low: ₹40.00
Off 52W high: -44.80%
1M return: -12.62%
3M return: -19.67%
6M return: -15.36%
1Y return: -36.02%
20D avg volume: 6,789
50 DMA: ₹47.96
200 DMA: ₹53.29

Key ratios Consolidated

Market cap: ₹78.62 Cr
Current price: ₹41.95
52W high / low: ₹76.00 / ₹40.00
Face value: ₹10.00
P/E: 578.10
P/B: —
EPS (TTM): ₹0.07
Book value / share: —
ROE: —
ROCE: 13.80%
Operating margin: —
Net margin: —
Debt / equity: 0.00
Net debt: ₹-1.29 Cr
Interest cover: 58.00
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: -2,847.0 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	0.00	0.00	0.00	0.03	0.02	0.00	—
	0.54	0.66	0.52	0.52	4.61	0.77	—
	0.34	0.55	0.33	0.40	0.34	0.37	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.04	0.03	0.02	0.02	0.02	-0.08	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.30	0.52	0.31	0.38	0.32	0.45	—
	0.20	0.11	0.19	0.14	4.28	0.40	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.20	0.11	0.19	0.14	4.28	0.40	—
	0.05	0.15	0.17	0.13	0.13	0.04	—
	0.15	-0.04	0.02	0.01	4.15	0.36	—
	0.08	-0.02	0.01	0.01	2.22	0.19	—
Key metrics
	0.20	0.11	0.19	0.14	4.28	0.40	—
	—	—	—	466.70%	21,400.00%	—	—
	—	—	—	33.30%	20,750.00%	—	—
	—	0.30%	—	0.40%	—	1.30%	—
	-100.00%	—	—	—	—	—	—
	-96.40%	-111.10%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	0.03	0.05	0.00	—
	2.24	6.30	2.72	—
	1.62	1.63	2.15	—
	0.00	0.00	0.00	—
	0.00	0.00	0.00	—
	0.11	0.10	0.41	—
	0.00	0.00	0.01	—
	0.00	0.00	0.00	—
	1.51	1.53	1.73	—
	0.64	4.73	0.57	—
	0.00	0.00	0.00	—
	0.64	4.73	0.57	—
	0.50	0.59	0.18	—
	0.14	4.14	0.39	—
	0.08	2.21	0.21	—
Key metrics
	0.64	4.73	0.58	—
	2,133.33%	9,460.00%	—	—
	466.67%	8,280.00%	—	—
	—	13.80%	1.90%	—
	—	961.50%	—	—
	—	0.62	1.54	—
	—	0.15	3.95	—
	—	0.00	0.00	—
	—	-1.29	-0.20	—
	—	-2,847.0	—	—
Balance sheet
	—	37.60	36.83	—
	—	36.90	34.11	—
	—	1.29	0.20	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	—	0.00	—
	—	0.00	0.00	—
	—	0.39	4.35	—
	—	3.26	6.62	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	34.35	30.21	—
Cash flow
	—	0.62	1.54	—
	—	0.46	-29.10	—
	—	0.00	-79.65	—
	—	0.00	0.00	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.53	0.66	0.52	0.52	4.61	0.77	—
	0.31	0.53	0.31	0.37	0.30	0.37	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.03	0.02	0.02	0.02	0.02	-0.08	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.28	0.51	0.29	0.35	0.28	0.45	—
	0.22	0.12	0.21	0.15	4.31	0.40	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.22	0.12	0.21	0.15	4.31	0.40	—
	0.05	0.15	0.17	0.13	0.13	0.04	—
	0.18	-0.03	0.04	0.02	4.18	0.36	—
	0.09	-0.02	0.02	0.01	2.23	0.19	—
Key metrics
	0.22	0.12	0.21	0.15	4.31	0.40	—
	—	0.40%	—	0.40%	—	1.30%	—
	-95.70%	-108.30%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	0.00	0.00	0.00	—
	2.23	6.30	2.72	—
	1.52	1.51	2.13	—
	0.00	0.00	0.00	—
	0.00	0.00	0.00	—
	0.09	0.09	0.41	—
	0.00	0.00	0.01	—
	0.00	0.00	0.00	—
	1.43	1.42	1.71	—
	0.70	4.79	0.59	—
	0.00	0.00	0.00	—
	0.70	4.79	0.59	—
	0.50	0.59	0.18	—
	0.21	4.20	0.41	—
	0.10	2.24	0.22	—
Key metrics
	0.70	4.79	0.60	—
	—	14.00%	2.00%	—
	—	924.40%	—	—
	—	0.28	1.77	—
	—	0.07	4.32	—
	—	0.00	0.00	—
	—	-0.85	-0.11	—
Balance sheet
	—	36.97	36.57	—
	—	36.47	34.02	—
	—	0.85	0.11	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	—	0.00	—
	—	0.00	0.00	—
	—	0.37	4.34	—
	—	2.80	6.61	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	34.17	29.96	—
Cash flow
	—	0.28	1.77	—
	—	0.46	-27.30	—
	—	0.00	-79.65	—
	—	0.00	0.00	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 62.71%

Holder	Type	Holding	Previous	Change
FORTIS HOSPITALS LIMITED	Promoter	62.71%	—	—
INVESTOR EDUCATION AND PROTECTION FUND AUTHORITY M	Public	4.86%	—	—
RUCKMANI NATARAJAN	Public	2.07%	—	—
SUNITA KANTILAL VARDHAN	Public	1.27%	—	—
A M GOPALAN	Public	1.23%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Relevant Disclosure is attached5 Aug 2026 · Company Update / Newspaper Publication
Relevant Disclosure is attached4 Aug 2026 · Result / Financial Results
Approval of Financial Results for the quarter ended June 30, 20264 Aug 2026 · Board Meeting / Outcome of Board Meeting
The relevant disclosure is attached29 Jul 2026 · AGM/EGM / AGM
The relevant disclosure is attached29 Jul 2026 · Company Update / General
Proceedings of 35th AGM29 Jul 2026 · AGM/EGM / AGM
Fortis Malar Hospitals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve Un-audited Finacial ....28 Jul 2026 · Board Meeting / Board Meeting
Please find the relevent disclosure attached.9 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Relevant Disclosure is attached.3 Jul 2026 · Company Update / Newspaper Publication
Relevant disclosure is attached.2 Jul 2026 · Company Update / General
Annual Report for the Financial Year 2025-20262 Jul 2026 · Others / Reg. 34 (1) Annual Report
Please find attached Notice of 35th Anuual General Meeting scheduled to be held on July 29, 20262 Jul 2026 · AGM/EGM / AGM
The relevant disclosure is attached1 Jul 2026 · Company Update / Newspaper Publication
The relevant disclosure is attached.24 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
The relevant disclosure is attached .5 Jun 2026 · Company Update / General
Please find attached the Annual Secretarial Compliance Report for the Financial Year ended March 31, 2026.26 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Relevant disclosures attached.19 May 2026 · Company Update / Newspaper Publication
Relevant disclosures attached18 May 2026 · Company Update / General
Relevant disclosures attached18 May 2026 · Company Update / Code of Conduct under SEBI (PIT) Regulations, 2015
Relevant disclosures attached18 May 2026 · Board Meeting / Outcome of Board Meeting
relevant disclosures attached18 May 2026 · Result / Financial Results
Fortis Malar Hospitals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 ,inter alia, to consider and approve the Audited Financial ....11 May 2026 · Board Meeting / Board Meeting
The relevant disclosure is attached.8 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The attached disclosure is an update on the demand raised by Income Tax Order Order for AY 2024-2528 Mar 2026 · Company Update / General
The relevant disclosure is attached.27 Mar 2026 · AGM/EGM / Postal Ballot
The relevant disclosure is attached.27 Mar 2026 · AGM/EGM / Postal Ballot
The relevant disclosure is attached.25 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
The relevant disclosure is attached.25 Mar 2026 · Company Update / General
The relevant disclosure is attached.16 Mar 2026 · Company Update / General
The relevant disclosure is attached.26 Feb 2026 · Company Update / Newspaper Publication
The relevant disclosure is attached.25 Feb 2026 · Company Update / General
The relevant disclosure is attached.25 Feb 2026 · AGM/EGM / Postal Ballot
The relevant disclosure is attached7 Feb 2026 · Company Update / Newspaper Publication
The relevant Disclosure is attached6 Feb 2026 · Result / Financial Results
The relevant disclosure is attached .6 Feb 2026 · Board Meeting / Outcome of Board Meeting
Fortis Malar Hospitals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 ,inter alia, to consider and approve Un-audited Financial ....30 Jan 2026 · Board Meeting / Board Meeting
The relevant disclosure is attached18 Jan 2026 · Company Update / Change in Directorate
The relevant disclosure is attached7 Jan 2026 · Company Update / General
The relevent disclosure is attached.7 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The relevant disclosure is attached.2 Jan 2026 · Company Update / General

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 2.5000	24 Jul 2024	24 Jul 2024	—

Board meetings

4 Aug 2026 Board Meeting - Financial Results